Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Lilly decision spells end for inhaled insulin

March 12, 2008 Research and Development

Regulatory problems and doubts about commercial potential have led Lilly to abandon its late-stage inhaled insulin product. The AIR insulin …
News

Putting UK pharma centre stage

March 7, 2008 Research and Development, Sales and Marketing innovation, pharma

Feature

Renovo wounded by cosmetic drug setback

March 7, 2008 Research and Development, Sales and Marketing

UK biotech company Renovo has received disappointing clinical trial results for its new anti-scarring and wound healing drug Juvista. The …
News

Working with NICE: the ingredients for success

February 29, 2008 Research and Development, Sales and Marketing NICE, healthcare, industry relations, pharma

NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …
Feature

GlaxoSmithKline’s Tyverb poised for launch in the UK

February 27, 2008 Research and Development

GlaxoSmithKline says its new breast cancer drug Tyverb is ready for launch and could be prescribed to the first UK …
News

Boehringer Ingelheim’s anti-clotting pill ready for launch

February 15, 2008 Research and Development

Boehringer Ingelheim's Pradaxa is expected to gain final regulatory approval shortly and could make a major impact in the anti-thrombosis …
News

Latest news from Datamonitor

February 15, 2008 Research and Development

Introgen and Moffitt initiate Phase II lung cancer trial Introgen Therapeutics and Moffitt Cancer Center have reported that a randomized, …
News

Wellcome Trust boosts medical research funding

February 8, 2008 Research and Development

Research charity the Wellcome Trust will increase its funding for medical research by more than £1 billion over the next …
News

Biovitrum to focus on specialist care

February 8, 2008 Research and Development

Swedish biopharmaceutical company Biovitrum is to turn its back on mass market disease areas and re-focus around specialist care projects. …
News

Collaborations with diagnostic firms ‘crucial to oncology progress’

February 6, 2008 Research and Development

Pharma companies should engage diagnostics companies in early phase talks if they want to fast-track innovative new cancer treatments to …
News

Latest news from Datamonitor

February 1, 2008 Research and Development

News

‘Alsace Biovalley’ brand launched to promote region’s biotech innovation

January 28, 2008 Research and Development Alsace, France, biotech

France has re-branded its leading biotech cluster the ‘Alsace Biovalley’ to help the region compete for investment in Europe and …
News

Latest news from Datamonitor

January 24, 2008 Research and Development

Access licenses MuGard to Rhei Pharmaceuticals Access Pharmaceuticals and Rhei Pharmaceuticals have signed a definitive licensing agreement under which Rhei …
News

Roche invests in Germany and Swiss biotech sites

January 18, 2008 Manufacturing and Production, Research and Development

Swiss pharmaceutical company Roche is to invest $390 million (430 million Swiss francs) in three of its European sites to …
News

Pharmafocus: A Year in Review

January 17, 2008 Research and Development, Sales and Marketing 2007, biotech, pharma, year in review

 A look back at some of the biggest stories to affect the UK pharmaceutical industry in 2007, including a string …
Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026